Atıf İçin Kopyala
ŞÜKÜR Y. E., Ulubasoglu H., Ilhan F. C., BERKER B., SÖNMEZER M., ATABEKOĞLU C. S., ...Daha Fazla
CLINICAL AND EXPERIMENTAL REPRODUCTIVE MEDICINE-CERM, cilt.47, sa.4, ss.300-305, 2020 (ESCI)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
47
Sayı:
4
-
Basım Tarihi:
2020
-
Doi Numarası:
10.5653/cerm.2020.03804
-
Dergi Adı:
CLINICAL AND EXPERIMENTAL REPRODUCTIVE MEDICINE-CERM
-
Derginin Tarandığı İndeksler:
Emerging Sources Citation Index (ESCI), Scopus, Academic Search Premier
-
Sayfa Sayıları:
ss.300-305
-
Anahtar Kelimeler:
Assisted reproductive technology, Dual trigger, Final oocyte maturation, GnRH agonist, Normal response, FINAL OOCYTE MATURATION, HUMAN CHORIONIC-GONADOTROPIN, LUTEINIZING-HORMONE SURGE, GNRH AGONIST, IVF CYCLES, INDUCTION, HCG, STIMULATION, RISK
-
Ankara Üniversitesi Adresli:
Evet
Özet
Objective: The feasibility of a gonadotropin-releasing hormone agonist (GnRHa) trigger in normal responders is still a matter of debate. The aim of this study was to compare the number of mature oocytes, the number of good-quality embryos, and the live birth rate in normal responders triggered by GnRHa alone, GnRHa and human chorionic gonadotropin (hCG; a dual trigger), and hCG alone.